# Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

> **NCT03911739** · — · COMPLETED · sponsor: **T. John Winhusen, PhD** · enrollment: 71 (actual)

## Conditions studied

- Opioid-Related Disorders
- Drug Addiction
- Pregnancy Related
- Substance Abuse
- Drug Abuse
- Neonatal Abstinence Syndrome
- Neonatal Opiate Withdrawal Syndrome
- Drug Abuse in Pregnancy

## Interventions

- **DRUG:** Buprenorphine Injection
- **DRUG:** Buprenorphine Sublingual Product

## Key facts

- **NCT ID:** NCT03911739
- **Lead sponsor:** T. John Winhusen, PhD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-14
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03911739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03911739, "Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT03911739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*